“…The data available at present, however, point to the similarities of the profiles of inflammatory mediators in septic patients with and without neutropenia [12,21]. In contrast, clinical descriptions of the manifestations of SIRS among neutropenic patients with cancer are scarce and controversial [15,22,25]. Some studies have focused on neutropenic critically ill cancer patients [3,4,8,11,15,22,25], but they do not clarify whether there are additional implications for neutropenia when septic shock ensues, and there is no consistent view as to its repercussions on overall ICU survival [14,28].…”